A retrospective study of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in preventing neutropenia during definitive concurrent chemoradiotherapy in patients with esophageal squamous carcinoma

Objective: To compare the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for preventive or delayed treatment in neutropenia, completion rate of concurrent chemoradiotherapy and hospitalization rate in patients with esophageal squamous carcinoma...

Full description

Bibliographic Details

Published in:	Radiation Medicine and Protection
Main Authors:	Xin Dong, Wei Deng, Leilei Jiang, Dan Yang, Huiming Yu, Dongming Li, Anhui Shi, Rong Yu, Weihu Wang
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Subjects:	Esophageal squamous carcinoma Concurrent chemoradiotherapy Pegylated recombinant human granulocyte colony-stimulating factor
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666555722000223